416 Impact of prior authorizations on dermatology patients at a large academic center

Abstract

Prescription drugs in dermatology have been increasingly subject to prior authorization (PA) policies, adding burdens and barriers to both patients and providers. However, few studies have formally characterized their effect on patients. Newly prescribed dermatology medications commonly requiring PAs in 2017 at a large academic institution were retrospectively reviewed (n=515). For each prescription, whether PA was required, PA decision if applicable, and whether follow-up clinic visit occurred within 6 months were assessed.